Company / Shares Outstanding
ADMA Biologics, Inc. Shares Outstanding History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
236.6M
FY2025
5-year range
104.9M / 236.6M
FY2021-FY2025
Trend
+4.7%
vs FY2024
Sector context
#37 of 212
Health Care
What the data says
ADMA Biologics, Inc.'s shares outstanding of 236620545.00 is higher than 83% of companies in the Health Care sector (FY2025). Shares Outstanding has increased for 9 consecutive years, from 10713087.00 in FY2016 to 236620545.00 in FY2025.
Based on SEC 10-K filings.
236620545.00 in FY2025 with a 5-year CAGR of +31.9%. Top quartile in the Health Care sector.
Increased from 221816930.00 to 236620545.00 over the past 2 years.
Health Care sector context is included.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- +6.5%
- 5-Year CAGR
- +31.9%
- 10-Year CAGR
- -
Sector benchmark
-22.7% below sector average
Key checks
Key Insights
- ADMA Biologics, Inc.'s shares outstanding has grown for 9 consecutive years.
- In FY2025, shares outstanding increased 4.7% year-over-year.
- Ranks #37 out of 212 companies in the Health Care sector.
- Lowest shares outstanding in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 3.37 (safe zone, above 2.9 threshold)
- Strong profit margin: 46.4%
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 236.6M | +4.7% |
| FY2024 | 226.1M | +1.9% |
| FY2023 | 221.8M | +13.3% |
| FY2022 | 195.8M | +86.7% |
| FY2021 | 104.9M | +76.8% |
| FY2020 | 59.3M | +28.0% |
| FY2019 | 46.4M | +26.2% |
| FY2018 | 36.7M | +185.0% |
| FY2017 | 12.9M | +20.3% |
| FY2016 | 10.7M | +15.3% |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026